Consulting Expertise & Services

Expertise

• Translational Science & Asset Development:
  Specialized in transforming scientific discoveries from high-density multi-omic data into actionable, commercially viable assets for the pharmaceutical, biotech, and health/wellness industries. Deep experience in bridging early scientific innovation with business fundamentals to de-risk and advance asset pipelines, from target discovery through preclinical and early clinical phases.

• Multi-Disciplinary Leadership:
  Over a decade of executive experience managing cross-functional R&D, clinical, and analytics teams—inclusive of multi-million dollar program budgets—within high-growth biotech and pharma environments. Skilled in developing scientific strategy, forging strategic academic and industry partnerships, and securing both dilutive and non-dilutive financing.

• Technological Innovation:
  Proven track record in integrating biology, technology, and AI/analytics, including mass spectrometry-based multi-omic platforms, Bayesian machine learning models for drug discovery, and development of novel diagnostic panels across oncology, neurology, metabolic and rare diseases.

• Regulatory & Clinical Development:
  Led programs on regulatory compliance, IND/Orphan Drug submissions, clinical protocol development, and partnership with CROs. Advanced both small and large molecule therapeutics into clinical stages and drove clinical operations and regulatory timelines to successful outcomes.

• Education & Scientific Communication:
  Former academic leader in pharmacy, pharmacology, and toxicology education. Recognized for designing cutting-edge, translational teaching modules, and actively presenting scientific progress to boards, investors, and the broader scientific and business community.

Services

• Strategic Consulting for Startups, Pharma, and Investors:

  • Scientific and commercial due diligence

  • Asset and pipeline evaluation

  • De-risking and validation strategies from discovery to clinical development

• R&D and Translational Science Solutions:

  • Biomarker-driven target identification and validation

  • Integrated analytics, AI/ML approaches for target discovery and asset development

  • Preclinical study design and management

• Regulatory, Clinical, and Commercialization Support:

  • IND/Orphan Drug application development and regulatory strategy

  • Clinical protocol creation and execution management

  • Diagnostic and therapeutic product development pathways

• Innovation & Partnership Development:

  • Strategic partnership facilitation between academia, industry, and investors

  • Custom scientific packages for business development and financing

  • Guidance through fundraising, investor engagements, and exit strategy planning